SSRI safety in overdose

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 15, 1998, Pages 42-48

  Barbey, Jean T ^a   Roose, Steven P ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; MAPROTILINE; NALOXONE; OXAZEPAM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TEMAZEPAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ARTICLE; CLINICAL FEATURE; DEPRESSION; DRUG OVERDOSE; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SEIZURE;

ADULT; CHILD; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; HUMANS; OVERDOSE; PAROXETINE; POISON CONTROL CENTERS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; UNITED STATES;

EID: 0031670607     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Shaw DM, Thomas DR, Briscoe MH, et al. A comparison of the antidepressant action of citalopram and amitriptyline. Br J Psychiatry 1986;149: 515-517
2. Hale AS, Stokes, PE. The utility of serotonin reuptake inhibitors in endogenous and severe depression. In: Freeman HL, ed. The Uses of Fluoxetine in Clinical Practice. London, England: Royal Society of Medicine Services Unlimited; 1991:15-25
3. Cole JO. A Review of Sertraline, a Unique Serotonin Reuptake Inhibitor. Presented at the symposium New Directions in Antidepressant Therapy; June 12, 1991; San Gimignano, Italy
4. Cohn JB, Crowder JE, Wilcox CS, et al. A placebo and imipramine controlled study of paroxeline. Psychopharmacol Bull 1990;26:185-189
5. Stokes PE. A primary care perspective on management of acute and long term depression. J Clin Psychiatry 1993;54(8, suppl):74-84
6. Litovitz TL, Schmitz BF, Matyunas N, et al. 1987 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1988;6:479-515
7. Litovitz TL, Schmitz BF, Holm KC. 1988 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1989;7:495-545
8. Litovitz TL, Schmitz BF, Bailey KM. 1989 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1990;8:394-442
9. Litovitz TL, Bailey KM, Schmitz BF, et al. 1990 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1991;9:461-509
10. Litovitz TL, Holm KC, Bailey KM, et al. 1991 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med 1992;10:452-505
11. Litovitz TL, Holm KC, Clancy C, et al. 1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1993;11:494-555
12. Lilovitz TL, Clark LR, Soloway RA. 1993 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1994;12:546-584
13. Litovitz TL, Felberg L, Soloway RA, et al. 1994 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1995;13:551-597
14. Litovitz TL, Felberg L, White S, et al. 1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1996;14:487-537
15. Litovitz TL, Smilkstein M, Felberg L, et al. 1996 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1997;15:447-500
16. Kincaid RL, McMullin MM, Crookham SB, et al. Report of a fluoxetine fatality. J Anal Toxicol 1990;14:327-329
17. Öström M, Eriksson A, Thorson J, et al. Fatal overdose with citalopram. Lancet 1996;348:339-340
18. Physicians' Desk Reference, Montvale. NJ: Medical Economics; 1997
19. Borys DJ, Setzer SC, Ling LJ, et al. The effects of fluoxetine in the overdose patient. J Toxicol Clin Toxicol 1990;28:331-340
20. Spiller HA, Morse S, Muir C. Fluoxetine ingestion: a one year retrospective study. Vet Hum Toxicol 1990;32:153-155
21. Borys DJ, Setzer SC, Ling LJ, et al. Acute fluoxetine overdose: a report of 234 cases. Am J Emerg Med 1992;10:115-120
22. Phillips S, Brent J, Kulig K, et al. Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdose. J Emerg Med 1997;15:439-445
23. Feierabend RH Jr. Benign course in a child with a massive fluoxetine overdose. J Fam Pract 1995;41:289-291
24. Braitberg G, Curry SC. Seizure after isolated fluoxetine overdose. Ann Emerg Med 1995;26:234-237
25. Riddle MA, Brown N, Dzubinski D, et al. Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 1989;28:587-588
26. Rohrig TP, Prouty RW. Fluoxetine overdose: a case report. J Anal Toxicol 1989;13:305-307
27. Graudins A, Vossler C, Wang R. Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy. Am J Emerg Med 1997;15:501-503
28. Klein-Schwartz W, Anderson B. Analysis of sertraline-only overdoses. Am J Emerg Med 1996;14:456-458
29. Lau GT, Horowitz BZ. Sertraline overdose. Acad Emerg Med 1996;3: 132-136
30. Caracci G. Unsuccessful suicide attempt by sertraline overdose [letter]. Am J Psychiatry 1994;151:147
31. Myers LB, Dean BS, Krenzelok EP. Paroxetine (Paxil): overdose assessment of a new selective serotonin reuptake inhibitor [abstract]. Vet Hum Toxicol 1994:36:370
32. Myers LB, Krenzelok EP. Paroxetine (Paxil) overdose: a pediatric focus. Vet Hum Toxicol 1997;39:86-88
33. Gorman SE, Rice T, Simmons HF. Paroxetine overdose [letter]. Am J Emerg Med 1993;11:682
34. Garnier R, Azoyan P, Chataigner D, et al. Acute fluvoxamine poisoning. J Int Med Res 1993;21:197-208
35. Personne M, Persson H, Sjoberg E. Citalopram toxicity. Lancet 1997;350: 518-519
36. Grundemar L, Wohlfart B, Lagerstedt C, et al. Symptoms and signs of severe citalopram overdose [letter]. Lancet 1997;349:1602